Xarelto (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Xarelto drug offered from Avera McKennan Hospital. This Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: rivaroxaban
SUBSTANCE NAME: RIVAROXABAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-03-16
END MARKETING DATE: 0000-00-00


Xarelto HUMAN PRESCRIPTION DRUG Details:

Item DescriptionXarelto from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 15(mg/1)
START MARKETING DATE: 2015-03-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0578_d960fd15-08c7-4f83-91a1-de864e88c243
PRODUCT NDC: 69189-0578
APPLICATION NUMBER: NDA202439

Other RIVAROXABAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalXarelto
Cardinal HealthXarelto
Janssen Pharmaceuticals, Inc.Xarelto